Header
For Healthcare Professionals

India: Other safety

3-2-1 banner

Other safety

No increased risk of hypoglycaemia¹

16-9-copy-3@2x
16-9-copy-3@2x

FDC: Fixed-dose combination. EMPA: Empagliflozin. LINA: Linagliptin.

 

Reference:
  1. DeFronzo RA, et al. Adv Ther. 2018;35(7):1009-22.

Lower incidence of GTI vs. Empagliflozin alone1

16-9-copy-3@3x
16-9-copy-3@3x

FDC: Fixed-dose combination. EMPA: Empagliflozin. LINA: Linagliptin. GTI: Genital tract infection.

 

Reference:
  1. DeFronzo RA, et al. Adv Ther. 2018;35(7):1009-22.

MLR ID: PC-IN-104937
Expiry Date: 7/9/2027